NCT05668754Phase 2Completed

Study of SDX in Patients With Idiopathic Hypersomnia (IH)

Study sponsor: Zevra Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-02-28Actual
Enrollment · participants66Actual
Source updated2026-06-30Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Actual enrollment decreased by 98 participants

Before: 164 participants (actual). After: 66 participants (actual).

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview